Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...
Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...
TORONTO and HAIFA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CA), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is ...
TORONTO and HAIFA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CA) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company ...
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency o ...
Privosegtor has received PRIME designation in Europe for the treatment of optic neuritis, a condition commonly seen in ...
India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...
Prospective assessment of renal function using cystatin C and functional MRI in children with newly diagnosed renal tumors. A combination chemotherapy, temozolomide (TMZ) with etoposide (VP), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results